<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260120068620N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-11-17</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the immediate effect of two manual therapy techniques on back thigh muscle flexibility in male athletes</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the immediate effect of the fascia distortion model (FDM) and muscle energy technique (MET) on hamstring muscle flexibility in non-professional male athletes</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-11-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>34</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/91922</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: After selecting eligible participants and obtaining their informed consent, each participant will be assigned a unique identification code. Subsequently, a random allocation sequence will be generated using computer software based on the simple randomization method. Participants will then be randomly assigned, with equal probability, to one of the two intervention groups: the Fascial Distortion Model (FDM)-based manual therapy group or the Muscle Energy Technique (MET) group. Group allocation will be carried out according to the random sequence generated by the software.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hamstring muscle flexibility.</hc_freetext>
      <i_freetext>Intervention 1: First Intervention Group: This group utilizes the Post Isometric Relaxation (PIR) method based on Lewit’s technique. The patient lies supine on the treatment table, and the hip joint is secured at a 90-degree angle using a sling. The therapist extends the patient’s knee until the first resistance to movement is felt and the patient reports discomfort or pain. The patient is then instructed to isometrically contract their leg muscles, pushing against the therapist’s shoulder with approximately 75% of their maximum voluntary contraction for 7-10 seconds. Following the contraction, the patient relaxes the muscle. After a 2-3 second pause, the therapist passively moves the patient’s knee into a new range of extension and holds this position for approximately 10 seconds. This cycle is repeated three times. Intervention 2: Second Intervention Group: In this group, the therapist performs the Triggerband technique based on the principles of the Fascial Distortion Model (Typaldos classification) and the patient’s body language. The therapist applies firm, localized pressure with their thumb along the hamstring muscle. This pressure is applied longitudinally, starting from the medial or lateral popliteal fossa and extending toward the ischial tuberosity. The pressure is maintained on the painful areas until the participant reports a reduction in pain or the resolution of discomfort.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The reason for selecting this option is the need for a thorough assessment of participant privacy considerations and ensuring the adequacy of the data anonymization process. We are also reviewing ethical requirements and the Informed Consent Form to ensure full compliance with data-sharing standards. Currently, our priority is to complete the study’s operational phase and primary analyses. A final decision regarding IPD sharing will be made upon study completion, in strict adherence to the ethical guidelines of the Institutional Ethics Committee.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Pazoki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.18, Shahid Reza Pazoki Alley, Khanmohammady Ave., Pakdasht Town</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3391975477</zip>
        <telephone>+98 21 3602 9988</telephone>
        <email>Pazoki20@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Pazoki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.18, Shahid Reza Pazoki Alley, Khanmohammady Ave., Pakdasht Town</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3391975477</zip>
        <telephone>+98 21 3602 9988</telephone>
        <email>Pazoki20@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inability to complete 20 degrees of extension, or exceeding the terminal range of active knee extension (AKE) in the preferred leg
Between 18 and 30 years of age
Non-professional athletes
Presence of pulling or burning pain according to the Trigger Point Distortion Pattern criteria during the AKE test
Written informed consent for participation in the study.
No use of any physical therapy or stretching techniques for the hamstring muscles within the past 2 weeks.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>30 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Presence of acute or chronic lower-extremity injuries within the past three months.
History of surgery involving the lumbar region or lower extremities.
Known neurological impairments or neuromuscular disorders, such as peripheral neuropathy, multiple sclerosis (MS), or spinal cord injuries.
Presence of severe deformities in the hip, knee, or lumbar spine.
Use of medications that affect muscle tone or function, such as muscle relaxants or nonsteroidal anti-inflammatory drugs (NSAIDs), within the past eight weeks.
The participant's unwillingness to undergo or continue the test.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First Intervention Group: This group utilizes the Post Isometric Relaxation (PIR) method based on Lewit’s technique. The patient lies supine on the treatment table, and the hip joint is secured at a 90-degree angle using a sling. The therapist extends the patient’s knee until the first resistance to movement is felt and the patient reports discomfort or pain. The patient is then instructed to isometrically contract their leg muscles, pushing against the therapist’s shoulder with approximately 75% of their maximum voluntary contraction for 7-10 seconds. Following the contraction, the patient relaxes the muscle. After a 2-3 second pause, the therapist passively moves the patient’s knee into a new range of extension and holds this position for approximately 10 seconds. This cycle is repeated three times.</i_keyword>
      <i_keyword>Second Intervention Group: In this group, the therapist performs the Triggerband technique based on the principles of the Fascial Distortion Model (Typaldos classification) and the patient’s body language. The therapist applies firm, localized pressure with their thumb along the hamstring muscle. This pressure is applied longitudinally, starting from the medial or lateral popliteal fossa and extending toward the ischial tuberosity. The pressure is maintained on the painful areas until the participant reports a reduction in pain or the resolution of discomfort.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Knee joint angle measured in the Active Knee Extension (AKE) test using a goniometer (in degrees). Timepoint: Baseline (after warm-up), immediately after intervention, and one hour after intervention. Method of measurement: Goniometer.</prim_outcome>
      <prim_outcome>Distance traveled in the Modified Sit &amp; Reach test using a Flex Tester Box (in centimeters). Timepoint: Baseline (after warm-up), immediately after intervention, and one hour after intervention. Method of measurement: Flex Tester Box.</prim_outcome>
      <prim_outcome>Level of pain or discomfort based on the Visual Analogue Scale (VAS) using a 10-cm ruler (score from 0 to 10). Timepoint: Baseline (after warm-up), immediately after intervention, and one hour after intervention. Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Net Vertical Jump height measured using the Chalk Method (in centimeters). Timepoint: Baseline (after warm-up), immediately after intervention, and one hour after intervention. Method of measurement: Chalk Method.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-12-25</approval_date>
        <contact_name>Ethics Committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Center of Headquarters of Tehran University of Medical Sciences, 6th Floor, Corner of Qods Ave., Keshavarz Blvd.. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
